Drug Profile
Pancrelipase immediate release - Nestle
Alternative Names: Viokace; ViokaseLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Wyeth
- Developer Nestle; Wyeth
- Class Pancreatic enzymes
- Mechanism of Action Pancrelipase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Pancreatic disorders
Most Recent Events
- 05 May 2020 Allergan has divested the drugs Zenpep and Viokace to Nestle